What was recalled
This page synthesizes the framework around niacin in commercial pet food. Niacin is the umbrella term for nicotinic acid and nicotinamide, two compounds with vitamin B3 activity. The biologically essential function is incorporation into NAD+ and NADP+, central electron-carrier cofactors for cellular oxidation-reduction reactions including glycolysis, the citric acid cycle, fatty acid oxidation, fatty acid synthesis, cholesterol biosynthesis, steroid hormone synthesis, and DNA repair. NAD+ depletion is now understood to play roles in cellular aging, neurodegenerative disease, and metabolic disease in human medicine; companion-animal aging biology is increasingly examining parallel mechanisms.
Commercial pet food niacin sources fall into three categories. Free niacin (nicotinic acid) is the carboxylic acid form, often used in industrial fortification and showing high stability through extrusion. Niacinamide (nicotinamide) is the amide form, also widely used and nutritionally equivalent in dogs and cats for NAD+ synthesis. Naturally occurring niacin in animal tissue (muscle meat, liver, fish) and grain bran (wheat bran, rice bran) contributes substantially to dietary niacin in named-meat-anchored and grain-inclusive formulations. AAFCO permits both synthetic forms and natural sources. The mammalian niacin requirement is partially met through endogenous synthesis from the amino acid tryptophan via the kynurenine pathway, but the conversion efficiency differs substantially between dogs and cats.
Why it was recalled
The structural controversy has two layers. Layer one — feline tryptophan-to-niacin conversion gap: mammals can synthesize niacin from dietary tryptophan via the kynurenine pathway, with quinolinic acid as the immediate precursor that is converted to NAD+. The efficiency of this conversion depends on the activity of quinolinate phosphoribosyltransferase (the enzyme converting quinolinate to NAD+ precursor) relative to picolinic acid carboxylase (the enzyme diverting quinolinate to picolinic acid, which is not converted to niacin). In dogs, the balance favors NAD+ synthesis; approximately 60 mg of dietary tryptophan substitutes for 1 mg of dietary niacin. In cats, the balance is heavily shifted by high picolinic acid carboxylase activity diverting most quinolinate away from NAD+ synthesis. The conversion efficiency in cats is therefore very low, and dietary niacin must meet essentially the full requirement from dietary or supplemental sources. AAFCO’s feline niacin minimum of 60 mg/kg dry matter (versus canine 13.6 mg/kg) reflects this metabolic specialization. The conversion gap is part of the broader feline obligate-carnivore framework alongside taurine, arachidonic acid, and pre-formed retinol.
Layer two — historical "black tongue" syndrome in dogs: the canine equivalent of human pellagra was the "black tongue" syndrome documented in the 1920s-1930s in dogs fed corn-based diets without supplementary protein or B-vitamin sources. Affected dogs showed black necrotic mucosa on the tongue and oral cavity, drooling, foul breath, and gastrointestinal disease (vomiting, bloody diarrhea); progression produced wasting and death. The syndrome was definitively resolved by Goldberger and colleagues (USPHS, 1928-1932) through dietary protein supplementation (the historical "P-P factor" — pellagra-preventive factor) and was instrumental in identifying niacin as an essential vitamin. Modern commercial dog food includes niacin supplementation at AAFCO-compliant levels; "black tongue" syndrome is historical rather than current.
Health risks for your pet
Clinical niacin deficiency in dogs and cats fed AAFCO-compliant commercial diets is rare at the population level. The historical canine "black tongue" syndrome and human pellagra are now historical references in companion-animal medicine. The highest-risk populations for niacin inadequacy are cats fed plant-protein-only diets without synthetic niacin supplementation (the obligate-carnivore conversion gap), cats and dogs with severe small-intestinal malabsorption, and animals fed prolonged unbalanced homemade diets. Clinical signs include stomatitis, glossitis, gastrointestinal disease, and in chronic severe cases neurological signs.
Niacin excess from dietary sources is uncommon but practical. High-dose oral niacin (nicotinic acid, not niacinamide) produces flushing reactions in some animals through prostaglandin-mediated cutaneous vasodilation; the syndrome is unpleasant but not dangerous. High-dose niacinamide is generally well tolerated. Chronic very high niacin dosing can produce hepatic injury in mammals broadly; the clinical relevance for companion animals on commercial diet is minimal. Supraphysiologic niacin supplementation has been studied for various indications in human and companion-animal medicine (canine osteoarthritis, atopic dermatitis adjunct) with mixed evidence; high-dose use should be veterinary-supervised.
What to do if you bought affected product
Pet owners can manage niacin adequacy through several practical approaches: (1) for cats, AAFCO-compliant commercial diets meet the elevated feline requirement through synthetic niacin supplementation; pet owners feeding cats should not rely on plant-only formulations without veterinary nutritionist oversight given the obligate-carnivore conversion gap; (2) for dogs, AAFCO-compliant commercial diets meet the canine requirement through a combination of synthetic supplementation and tryptophan-derived endogenous synthesis from named-meat ingredients; (3) watch for oral-cavity changes — stomatitis, glossitis, tongue color changes warrant veterinary evaluation, although in modern commercial-fed pets the causes are typically dental disease, autoimmune disease, or systemic illness rather than primary niacin deficiency; (4) do not give human high-dose niacin supplements without veterinary direction — flushing reactions can occur, and dosing for therapeutic indications in companion animals differs from human dosing; (5) for raw-feeding cats with high muscle meat and organ meat proportion, niacin intake is generally adequate from animal tissue without specific supplementation, but veterinary nutritionist oversight is appropriate for balanced raw and freeze-dried formulation; (6) verify B-complex adequacy in chronic gastrointestinal disease — IBD, exocrine pancreatic insufficiency, and severe small-intestinal disease can reduce B-vitamin absorption; veterinary B-complex supplementation may be indicated alongside underlying disease management.
How this affects KibbleIQ’s grade
The KibbleIQ rubric v15 does not currently differentiate niacin source form per our published methodology, since AAFCO-compliant commercial diets meet the canine and feline requirements through standard formulation. The structural feline obligate-carnivore conversion gap is appropriately addressed by the 4x higher feline AAFCO minimum (60 mg/kg vs 13.6 mg/kg dry matter for dogs). Future rubric extension under consideration: vegan and vegetarian feline formulations would be evaluated against documented synthetic niacin supplementation and veterinary nutritionist balance. The broader category effect is modest; niacin is a structurally well-addressed B-vitamin in commercial-fed populations.